Translational Cardiovascular Research Center
When
Where
Health Sciences Education Building, room C401
435 N. 5th Street, Phoenix, AZ 85004
or
Join Virtually
Event Description
In this seminar, Yanqiao Zhang, MD, will cover the role of hepatic activating transcription factor 3, or ATF3, in regulating lipid and lipoprotein metabolism, atherosclerosis and fatty liver disease. He will also elaborate on the role of adipocyte ATF3 in protection against fatty liver disease.
Presenter Details
Zhang is a professor and the director of diabetes, obesity and metabolism research at Northeast Ohio Medical University. He received his MD and MS degrees from Wuhan University. He moved to the United States in 1998 and did postdoctoral training at West Virginia University and the University of California in Los Angeles. In 2008, he was recruited by NEOMED as a tenure-track assistant professor and has been with NEOMED for 15 years.
Zhang’s research is focused on the regulation of lipid, lipoprotein and energy metabolism and the pathogenesis of fatty liver disease and atherosclerosis. His group has published papers in Nature Metabolism, Nature Communications, Hepatology, Molecular Therapy, Diabetes, and others. He has served on many NIH study sections as a standing or ad-hoc member. He is serving on the editorial board of Hepatology as a member and several other journals as an associate editor. He has trained many students and postdoctoral fellows, and some of them are now faculty members in academic institutions. His research is supported by NIH R01s.